120 related articles for article (PubMed ID: 6311129)
1. Successful ketoconazole treatment of protothecosis with ketoconazole-associated hepatotoxicity.
Pegram PS; Kerns FT; Wasilauskas BL; Hampton KD; Scharyj M; Burke JG
Arch Intern Med; 1983 Sep; 143(9):1802-5. PubMed ID: 6311129
[TBL] [Abstract][Full Text] [Related]
2. [Ketoconazole--a change in antimycotic therapy?].
Meinhof W
Hautarzt; 1983 Apr; 34(4):155-8. PubMed ID: 6303982
[No Abstract] [Full Text] [Related]
3. Hepatitis and ketoconazole therapy.
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1058-9. PubMed ID: 6271330
[No Abstract] [Full Text] [Related]
4. Potential and problems with ketoconazole.
Graybill JR
Am J Med; 1983 Jan; 74(1B):86-90. PubMed ID: 6295157
[No Abstract] [Full Text] [Related]
5. [Toxic hepatitis caused by ketoconazole (Nizoral)].
Boëtius G; Peeters JP; Peters JH
Ned Tijdschr Geneeskd; 1983 Feb; 127(8):341-3. PubMed ID: 6300702
[No Abstract] [Full Text] [Related]
6. [Hepatitis during the administration of ketoconazole (Nizoral)].
van Dijke CP
Ned Tijdschr Geneeskd; 1983 Feb; 127(8):339-41. PubMed ID: 6300701
[No Abstract] [Full Text] [Related]
7. Visceral protothecosis mimicking sclerosing cholangitis in an immunocompetent host: successful antifungal therapy.
Chan JC; Jeffers LJ; Gould EW; Hutson D; Martinez OV; Reddy KR; Hassan F; Schiff ER
Rev Infect Dis; 1990; 12(5):802-7. PubMed ID: 2237120
[TBL] [Abstract][Full Text] [Related]
8. [Toxic hepatitis caused by ketoconazole].
Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
[No Abstract] [Full Text] [Related]
9. Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.
Robertson MH; Hanifin JM; Parker F
Rev Infect Dis; 1980; 2(4):578-81. PubMed ID: 6255533
[TBL] [Abstract][Full Text] [Related]
10. Severe hepatitis during ketoconazole therapy.
Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
[TBL] [Abstract][Full Text] [Related]
11. Hepatic reactions during ketoconazole treatment.
Janssen PA; Symoens JE
Am J Med; 1983 Jan; 74(1B):80-5. PubMed ID: 6129799
[TBL] [Abstract][Full Text] [Related]
12. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
Tkach JR; Rinaldi MG
Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
[No Abstract] [Full Text] [Related]
13. Successful treatment with fluconazole of protothecosis developing at the site of an intralesional corticosteroid injection.
Kim ST; Suh KS; Chae YS; Kim YJ
Br J Dermatol; 1996 Nov; 135(5):803-6. PubMed ID: 8977687
[TBL] [Abstract][Full Text] [Related]
14. Ketoconazole and hepatic reactions.
Boughton K
S Afr Med J; 1983 Jun; 63(25):955. PubMed ID: 6304923
[No Abstract] [Full Text] [Related]
15. [Toxic hepatitis during the administration of ketoconazole (Nizoral)].
Kramer NJ; Montnor LP; Berghuis PH
Ned Tijdschr Geneeskd; 1983 Feb; 127(8):343-4. PubMed ID: 6300703
[No Abstract] [Full Text] [Related]
16. Hepatotoxic potential of ketoconazole under investigation.
FDA Drug Bull; 1982 Aug; 12(2):11-2. PubMed ID: 6292034
[No Abstract] [Full Text] [Related]
17. Human protothecosis.
Lass-Flörl C; Mayr A
Clin Microbiol Rev; 2007 Apr; 20(2):230-42. PubMed ID: 17428884
[TBL] [Abstract][Full Text] [Related]
18. Hepatic dysfunction and ketoconazole therapy.
Svejgaard E; Ranek L
Ann Intern Med; 1982 Jun; 96(6 Pt 1):788-9. PubMed ID: 6283980
[No Abstract] [Full Text] [Related]
19. Ketoconazole and the liver.
Strauss JS
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):546-7. PubMed ID: 6281318
[No Abstract] [Full Text] [Related]
20. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.
Petersen EA; Alling DW; Kirkpatrick CH
Ann Intern Med; 1980 Dec; 93(6):791-5. PubMed ID: 6255844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
